chartexchange

MXCT
MaxCyte, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 3:05:07 PM EST
1.27USD+1.594%(+0.02)1,353,105
Pre-marketNov 19, 2026 9:25:30 AM EST
1.32USD+5.179%(+0.06)
1.2700Bid1.2800Ask0.0100Spread
Loading…
Loading…
131.64M
Healthcare
Medical Devices
HQ
Rockville, MD, USA
Previous Close
$1.25
Beta
1.38
52-Week High
$1.81 2025-11-19
52-Week Low
$0.64 2026-02-17
SMA 50
$1.25
SMA 200
$1.07
Avg. Vol 10D
1.75M
Avg. Vol 30D
1.71M
Avg. Vol 90D
987,755
Relative Vol
0.77
103.25M
94.86M
0.2800%
3,100,000
MXCT Profile

MaxCyte is a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization.

MXCT Performance
PeriodPriceDateChangeBeta
1W1.192026-11-12+7.14%2.983
1M1.302026-10-19-1.92%1.499
3M1.392026-08-19-8.27%0.696
6M1.042026-05-19+22.60%1.376
1Y1.702025-11-19-25.00%1.377
2Y3.332024-11-19-61.71%—
5Y12.792021-11-19-90.03%1.413
MXCT Stock Summary

MaxCyte, Inc. Common Stock (NASDAQ:MXCT) stock price today is $1.28, and today's volume is 1,320,871. MXCT is up 2.000% today. The 30 day average volume is 1.71M. MXCT market cap is $131.64M with 103.25M shares outstanding.